Martinez-Ortega Jesus Ivan, Perez Hernandez Felipe de Jesus
Department of Dermatology, Dermatological Institute of Jalisco "Dr. Jose Barba Rubio", Zapopan, MEX.
Department of Internal Medicine, Pensiones Medical Center, Merida, MEX.
Cureus. 2023 Sep 7;15(9):e44860. doi: 10.7759/cureus.44860. eCollection 2023 Sep.
This case report examines a rare occurrence of chronic spontaneous urticaria (CSU) following the administration of the CoronaVac vaccine for COVID-19. The patient developed persistent urticarial lesions that appeared and disappeared over an extended period after receiving the vaccine. The diagnosis of CSU was supported by histopathological examination and the close temporal correlation between symptom onset and vaccination. The discussion focuses on the immune mechanisms involved in CSU, the potential triggers of allergic reactions to COVID-19 vaccines, and the importance of further research to identify specific allergenic components. This case underscores the need for vigilance in monitoring and reporting adverse events related to COVID-19 vaccination to ensure vaccine safety and optimize public health strategies.
本病例报告探讨了接种新冠病毒灭活疫苗(CoronaVac)后罕见出现慢性自发性荨麻疹(CSU)的情况。该患者在接种疫苗后出现了持续的荨麻疹皮损,这些皮损在较长一段时间内反复出现和消退。组织病理学检查以及症状出现与接种疫苗之间的紧密时间相关性支持了CSU的诊断。讨论聚焦于CSU所涉及的免疫机制、对新冠疫苗发生过敏反应的潜在触发因素,以及进一步研究以确定特定过敏原成分的重要性。该病例强调了在监测和报告与新冠疫苗接种相关的不良事件时保持警惕的必要性,以确保疫苗安全并优化公共卫生策略。